Latest News

Ibrutinib Active, Safe in Previously Treated Waldenström's Macroglobulinemia

Ibrutinib Active, Safe in Previously Treated Waldenström's Macroglobulinemia

Ibrutinib was highly active, associated with durable responses, and safe in pretreated patients with Waldenström's macroglobulinemia.

Neoadjuvant GC with MVAC Have Comparable Efficacy in Bladder Cancer

Neoadjuvant GC with MVAC Have Comparable Efficacy in Bladder Cancer

In muscle-invasive bladder cancer, gemcitabine plus cisplatin (GC) and methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) were comparable.

Copaxone Approved for Relapsing Multiple Sclerosis

Copaxone Approved for Relapsing Multiple Sclerosis

The FDA has approved Copaxone (glatiramer acetate injection) for treatment of patients with relapsing forms of multiple sclerosis.

For Prostate Cancer, Referral-Based Exercise Program Beneficial

For Prostate Cancer, Referral-Based Exercise Program Beneficial

For men with prostate cancer, clinician referral to and participation in an exercise program has a positive impact on mental health.

Enzalutamide Improves Quality of Life in Chemo-Naive Prostate Cancer

Enzalutamide Improves Quality of Life in Chemo-Naive Prostate Cancer

Enzalutamide improves health-related quality of life (HRQoL) in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).

Ibrance Plus Fulvestrant Improve Survival in Metastatic Breast Cancer

Ibrance Plus Fulvestrant Improve Survival in Metastatic Breast Cancer

Ibrance (palbociclib) plus fulvestrant met its primary endpoint in progression-free survival for HR+, HER2- metastatic breast cancer

Prolonged ADT Raises Diabetes, Cardiovascular Risk in Older Men

Prolonged ADT Raises Diabetes, Cardiovascular Risk in Older Men

For men with prostate cancer older than 70, prolonged androgen deprivation therapy associated with increased risk of diabetes and cardiovascular disease.

More Gene Testing for Cancer Should Include Normal Tissue

More Gene Testing for Cancer Should Include Normal Tissue

If genetic tests are only done on cancer tissue, as many as half of patients may not receive the most appropriate treatment for their cancer.

Capecitabine Plus Bevacizumab Effective as Maintenance for Colorectal Cancer

Capecitabine Plus Bevacizumab Effective as Maintenance for Colorectal Cancer

Maintenance treatment with capecitabine plus bevacizumab in metastatic colorectal cancer is effective.

Chlorambucil Plus Ofatumumab Safe, Effective for Treatment-Naive Chronic Leukemia

Chlorambucil Plus Ofatumumab Safe, Effective for Treatment-Naive Chronic Leukemia

Chlorambucil plus ofatumumab is an important treatment option for treatment-naive patients with chronic lymphocytic leukemia (CLL).

In Myelosuppressive Chemo, Filgrastim May Provide Survival Benefit

In Myelosuppressive Chemo, Filgrastim May Provide Survival Benefit

Filgrastim may provide a small survival benefit in patients with cancer who are receiving myelosuppressive chemotherapy.

Pancreatic Cancer Risk Inversely Linked with Statin Use

Pancreatic Cancer Risk Inversely Linked with Statin Use

Statin use is inversely associated with pancreatic cancer risk, with evidence of a sex-specific risk reduction.

Nanotechnology Breath Test May Identify Early Gastric Cancer

Nanotechnology Breath Test May Identify Early Gastric Cancer

A novel technology senses small changes in exhaled breath, and identifies changes that signal the development of gastric cancer.

Efficacy of Everolimus, Interferon Similar in Metastatic Renal Cell Carcinoma

Efficacy of Everolimus, Interferon Similar in Metastatic Renal Cell Carcinoma

Efficacy of first-line everolimus/bevacizumab and interferon alfa-2a/bevacizumab appears similar in metastatic renal cell carcinoma.

Autologous Stem Cell Transplantation Safe Without Transfusion Support

Autologous Stem Cell Transplantation Safe Without Transfusion Support

Autologous stem-cell transplantation (ASCT) can be safely performed without transfusion support.

Masitinib May Be Effective Treatment in Pancreatic Cancer Subgroups

Masitinib May Be Effective Treatment in Pancreatic Cancer Subgroups

Masitinib plus gemcitabine may be effective in the treatment of specific subgroups of patients with advanced pancreatic ductal adenocarcinoma (PDAC).

Cologuard At-Home Test Now Covered by Several Health Plans

Cologuard At-Home Test Now Covered by Several Health Plans

Exact Sciences Corp., maker of Cologuard, announced that several insurers are now covering the non-invasive colon cancer at-home test.

Aspirin Use Not Linked with Lower Prostate Cancer Mortality

Aspirin Use Not Linked with Lower Prostate Cancer Mortality

Aspirin use does not appear to reduce the risk of mortality associated with prostate cancer.

In Teen Boys, HPV4 Vaccine Cost-Effective for Oropharyngeal Prevention

In Teen Boys, HPV4 Vaccine Cost-Effective for Oropharyngeal Prevention

The quadrivalent human papillomavirus (HPV4) vaccine appears to be cost-effective for the prevention of oropharyngeal cancer (OPC).

Bendamustine Plus Rituximab May Be Safe, Effective for Lymphoma

Bendamustine Plus Rituximab May Be Safe, Effective for Lymphoma

Bendamustine plus rituximab safe in Japanese patients with relapsed/refractory indolent B-cell non-Hodgkin and mantle cell lymphomas.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs